Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dimova Velichka"'
Autor:
Reddy Venkata, Dhople Arvind, Kantardjiev Todor, Sato Katsumasa, Atanasova Ivana, Sano Chiaki, Daneluzzi Donna, Feshchenko Yurii, Geeta Nadadhur, Dimova Velichka, Zhivkova Zvetana, Yashina Ljudmila, Tomioka Haruaki, Toumanov Andrei, Gangadharam Patisapu
Publikováno v:
Recent Patents on Anti-Infective Drug Discovery. 5:76-90
A new rifamycin derivative 3-(4-cinnamyl-piperazinyl iminomethyl) rifamycin SV (T9) and its sodium salt (T11, Rifacinna®) were in vitro, in vivo, toxicologically and clinically investigated in comparison with rifampicin, rifapentine, rifabutin, rifa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d0e8f7c2f6324f9e640dc3db53c0159
https://doi.org/10.2174/157489110790112572
https://doi.org/10.2174/157489110790112572
Autor:
Dimova, Velichka, Atanasova, Ivana, Tomioka, Haruaki, Sato, Katsumasa, Reddy, Venkata, Geeta, Nadadhur, Daneluzzi, Donna, Kantardjiev, Todor, Dhople, Arvind, Feschenko, Yurii, Yashina, Ljudmila, Andrei, Toumanov, Zhivkova, Zvetana, Sano, Chiaki
Publikováno v:
Recent patents on anti-infective drug discovery. 5(1)
A new rifamycin derivative 3-(4-cinnamyl-piperazinyl iminomethyl) rifamycin SV (T9) and its sodium salt (T11, Rifacinna((R))) were in vitro, in vivo, toxicologically and clinically investigated in comparison with rifampicin, rifapentine, rifabutin, r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e0669e63f4e4e115a745b128a98d6062
https://pubmed.ncbi.nlm.nih.gov/19929844
https://pubmed.ncbi.nlm.nih.gov/19929844